MedTrace Logo

Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease

NCT00054600 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-08-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether Extracorporeal Photopheresis with UVADEX (ECP) prior to bone marrow or peripheral blood stem cell transplantation is effective in the prevention of Graft-versus-Host Disease (GvHD).

Conditions

  • Graft-versus-Host Disease

Interventions

DRUG

Methoxsalen

PROCEDURE

Extracorporeal Photopheresis

Sponsors & Collaborators

  • Mallinckrodt

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Completion
2004-06-30

Countries

  • United States
  • Australia
  • Brazil
  • Germany
  • Italy
  • Portugal
  • Slovakia
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00054600 on ClinicalTrials.gov